Showing results (401-410 of 447) with videos related to

Sort By:
Pageof 45
Transfusion Medicine (Oxford, England)|January 9, 1999
Risk of hepatitis C infection in neonates transfused with blood from donors infected with hepatitis CJ M O'Riordan, A Conroy, C Nourse, et al.
AIDS (London, England)|February 24, 2001
ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week resultsR L Murphy, S Brun, C Hicks, et al.
The Journal of Infectious Diseases|March 9, 1999
Treatment with amprenavir alone or amprenavir with zidovudine and lamivudine in adults with human immunodeficiency virus infection. AIDS Clinical Trials Group 347 Study TeamR L Murphy, R M Gulick, V DeGruttola, et al.
Clinical and Diagnostic Laboratory Immunology|November 1, 2001
Skin test reactivity and cellular immune responses to Mycobacterium avium sensitin in AIDS patients at risk for disseminated M. avium infectionC F von Reyn, P L Williams, H M Lederman, et al.
AIDS (London, England)|July 9, 1999
Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group Protocol 306 InvestigatorsD R Kuritzkes, I Marschner, V A Johnson, et al.
AIDS (London, England)|September 13, 2000
Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370D R Kuritzkes, R L Bassett, V A Johnson, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|July 17, 2019
Second-line antiretroviral therapy failure and characterization of HIV-1 drug resistance patterns in children in MaliM Sylla, O Dolo, A I Maiga, et al.
The New England Journal of Medicine|December 24, 1998
Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials GroupW M El-Sadr, R L Murphy, T M Yurik, et al.
Molecular Cell|April 24, 2026
PDS5 proteins control genome architecture by limiting the lifetime of cohesin-NIPBL complexesGordana Wutz, Iain F Davidson, Edward J Banigan, et al.
Public Health|December 21, 2021
COVID-19 and tobacco cessation: lessons from IndiaM Arora, G P Nazar, N Sharma, et al.
Pageof 45